a In-vitro metabolites noticed in common amongst respective 7 most considerable metabolites in b C. elegans, c HLM and d HepG2 products.The possibility of deacylation in vivo and also the conversion into AL-LAD or MIPLA should be even further investigated. In addition, there are worries about the future distribution of sheet drug